Hypoxia imaging with (18)F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts

BACKGROUND: Esophageal cancer is an aggressive disease with poor survival rates. A more patient-tailored approach based on predictive biomarkers could improve outcome. We aimed to predict radiotherapy (RT) response by imaging tumor hypoxia with (18)F-FAZA PET/CT in an esophageal adenocarcinoma (EAC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Melsens, Elodie, De Vlieghere, Elly, Descamps, Benedicte, Vanhove, Christian, Kersemans, Ken, De Vos, Filip, Goethals, Ingeborg, Brans, Boudewijn, De Wever, Olivier, Ceelen, Wim, Pattyn, Piet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842657/
https://www.ncbi.nlm.nih.gov/pubmed/29514673
http://dx.doi.org/10.1186/s13014-018-0984-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842657/
https://www.ncbi.nlm.nih.gov/pubmed/29514673
http://dx.doi.org/10.1186/s13014-018-0984-3

Ejemplares similares